Secreted phospholipase A2 type II is present in Paget's disease of bone and modulates osteoclastogenesis, apoptosis and bone resorption of human osteoclasts independently of its catalytic activity in vitro
- 1 February 2014
- journal article
- research article
- Published by Elsevier in Prostaglandins, Leukotrienes and Essential Fatty Acids
- Vol. 90 (2-3) , 39-45
Abstract
No abstract availableKeywords
Funding Information
- Canadian Institutes of Health Research and the Canadian Arthritis Network
- FRSQ scholarship
This publication has 41 references indexed in Scilit:
- Group III secreted phospholipase A2 transgenic mice spontaneously develop inflammationBiochemical Journal, 2009
- Phospholipase A2 structure/function, mechanism, and signalingJournal of Lipid Research, 2009
- Phospholipase A2 BiochemistryCardiovascular Drugs and Therapy, 2008
- Prostaglandin D2 Receptors Control Osteoclastogenesis and the Activity of Human OsteoclastsJournal of Bone and Mineral Research, 2008
- Molecular Targets of Rheumatoid ArthritisInflammation & Allergy - Drug Targets, 2008
- Arachidonic acid inhibits osteoblast differentiation through cytosolic phospholipase A2‐dependent pathwayOral Diseases, 2007
- RETRACTED: Secretory phospholipase A2 IIA is up-regulated by TNF-α and IL-1α/β after transient focal cerebral ischemia in ratBrain Research, 2007
- Interleukin-1, interleukin-6, and interleukin-10 responses after antibiotic treatment in experimental chronic Staphylococcus aureus osteomyelitisJournal of Orthopaedic Science, 2006
- Potentiation of Tumor Necrosis Factor α-induced Secreted Phospholipase A2 (sPLA2)-IIA Expression in Mesangial Cells by an Autocrine Loop Involving sPLA2 and Peroxisome Proliferator-activated Receptor α ActivationJournal of Biological Chemistry, 2003
- Interleukin 1 and tumor necrosis factor synergistically stimulate prostaglandin synthesis and phospholipase A2 release from rat renal mesangial cellsBiochemical and Biophysical Research Communications, 1989